Daxor Corp (DXR) Short-Term Debt to Capital

The share price history of Daxor Corporation (DXR) reflects a trend currently valued at 0.00. Daxor Corporation generates revenue through the sale of high-precision blood flow monitoring systems and ancillary consumables for severe trauma therapy. Its sales geography spans global clinics and laboratories, which mitigates local budgetary risks. Current demand is supported by BVA-100 devices, although the slow implementation of standards is already priced in.

To minimize capital loss risks amid volatility, it is critical for investors to monitor the ratio of short-term liabilities to equity, which measures the proportion of current loans (up to one year) relative to the company's net assets. Analyzing this trend allows for an assessment of the liquidity of Daxor Corporation (DXR), whose outsourcing model for assembly and logistics requires precise short-term debt management to ensure uninterrupted service for laboratories.